Results

Reset All Filters

Manufacturer:Adooq remove filter

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

Click on the organs and learn more about cancer types

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

Name	Type	Specific against	Item no.	Amount	Price
Nelociguat	Inhibitors	Other	A20591-1000 Adooq	1000 mg	Login Compare	Nelociguat
Nelociguat	Inhibitors	Other	A20591-10mM-D Adooq	10 mM x 1 mL in DMSO	Login Compare	Nelociguat
LSD1-IN-6	Inhibitors	Other	A20474-1 Adooq	1 mg	Login Compare	LSD1-IN-6
LSD1-IN-6	Inhibitors	Other	A20474-5 Adooq	5 mg	Login Compare	LSD1-IN-6
LSD1-IN-6	Inhibitors	Other	A20474-10 Adooq	10 mg	Login Compare	LSD1-IN-6
LSD1-IN-5	Inhibitors	Other	A20479-1 Adooq	1 mg	Login Compare	LSD1-IN-5
LSD1-IN-5	Inhibitors	Other	A20479-5 Adooq	5 mg	Login Compare	LSD1-IN-5
LSD1-IN-5	Inhibitors	Other	A20479-10 Adooq	10 mg	Login Compare	LSD1-IN-5
Fumarate hydratase-IN-1	Inhibitors	Other	A20471-25 Adooq	25 mg	Login Compare	Fumarate hydratase-IN-1
Fumarate hydratase-IN-1	Inhibitors	Other	A20471-100 Adooq	100 mg	Login Compare	Fumarate hydratase-IN-1
Fumarate hydratase-IN-1	Inhibitors	Other	A20471-10mM-D Adooq	10 mM x 1 mL in DMSO	Login Compare	Fumarate hydratase-IN-1
LSD1-IN-6	Inhibitors	Other	A20474-25 Adooq	25 mg	Login Compare	LSD1-IN-6
LSD1-IN-6	Inhibitors	Other	A20474-50 Adooq	50 mg	Login Compare	LSD1-IN-6
LSD1-IN-6	Inhibitors	Other	A20474-100 Adooq	100 mg	Login Compare	LSD1-IN-6
LSD1-IN-5	Inhibitors	Other	A20479-25 Adooq	25 mg	Login Compare	LSD1-IN-5
LSD1-IN-5	Inhibitors	Other	A20479-50 Adooq	50 mg	Login Compare	LSD1-IN-5
LSD1-IN-5	Inhibitors	Other	A20479-100 Adooq	100 mg	Login Compare	LSD1-IN-5
UKI-1	Inhibitors	Other	A20516-25 Adooq	25 mg	Login Compare	UKI-1
UKI-1	Inhibitors	Other	A20516-100 Adooq	100 mg	Login Compare	UKI-1
UKI-1	Inhibitors	Other	A20516-10mM-D Adooq	10 mM x 1 mL in DMSO	Login Compare	UKI-1
PROTAC BET-binding moiety 2	Inhibitors	Other	A20655-5 Adooq	5 mg	Login Compare	PROTAC BET-binding moiety 2
PROTAC BET-binding moiety 2	Inhibitors	Other	A20655-10 Adooq	10 mg	Login Compare	PROTAC BET-binding moiety 2
PROTAC BET-binding moiety 2	Inhibitors	Other	A20655-50 Adooq	50 mg	Login Compare	PROTAC BET-binding moiety 2
PROTAC BET-binding moiety 2	Inhibitors	Other	A20655-100 Adooq	100 mg	Login Compare	PROTAC BET-binding moiety 2
B220	Inhibitors	Other	A20391-25 Adooq	25 mg	Login Compare	B220

Name Price

Nelociguat

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20591-1000
Amount	1000 mg
Available

Nelociguat

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20591-10mM-D
Amount	10 mM x 1 mL in DMSO
Available

LSD1-IN-6

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20474-1
Amount	1 mg
Available

LSD1-IN-6

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20474-5
Amount	5 mg
Available

LSD1-IN-6

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20474-10
Amount	10 mg
Available

LSD1-IN-5

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20479-1
Amount	1 mg
Available

LSD1-IN-5

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20479-5
Amount	5 mg
Available

LSD1-IN-5

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20479-10
Amount	10 mg
Available

Fumarate hydratase-IN-1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20471-25
Amount	25 mg
Available

Fumarate hydratase-IN-1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20471-100
Amount	100 mg
Available

Fumarate hydratase-IN-1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20471-10mM-D
Amount	10 mM x 1 mL in DMSO
Available

LSD1-IN-6

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20474-25
Amount	25 mg
Available

LSD1-IN-6

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20474-50
Amount	50 mg
Available

LSD1-IN-6

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20474-100
Amount	100 mg
Available

LSD1-IN-5

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20479-25
Amount	25 mg
Available

LSD1-IN-5

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20479-50
Amount	50 mg
Available

LSD1-IN-5

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20479-100
Amount	100 mg
Available

UKI-1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20516-25
Amount	25 mg
Available

UKI-1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20516-100
Amount	100 mg
Available

UKI-1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20516-10mM-D
Amount	10 mM x 1 mL in DMSO
Available

PROTAC BET-binding moiety 2

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20655-5
Amount	5 mg
Available

PROTAC BET-binding moiety 2

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20655-10
Amount	10 mg
Available

PROTAC BET-binding moiety 2

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20655-50
Amount	50 mg
Available

PROTAC BET-binding moiety 2

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20655-100
Amount	100 mg
Available

B220

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20391-25
Amount	25 mg
Available

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk

REGISTER & SECURE BENEFITS

Filter Results

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk